Latest Arrayit Corporation (ARYC) Headlines A
Post# of 170
Posted On: 03/08/2014 10:00:24 PM
Latest Arrayit Corporation (ARYC) Headlines
Arrayit Corporation Showcases High Sensitivity Diagnostic Microarray Technology at 21st International Molecular Medicine Tri-Conference
GlobeNewswire - Mon Feb 10, 12:09PM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is showcasing its high sensitivity, high specificity patented and proprietary microarray platform at the 21 International Molecular Medicine Tri-Conference in San Francisco, CA, USA on February 9-14, 2014. The conference, which features more than 3,000 researchers and clinicians from 35 countries, focuses on drug discovery, genomics, diagnostics and information technology.
Arrayit Corporation Showcases Advanced Robotic Microarray Technology at Laboratory Automation Conference 2014
GlobeNewswire - Tue Jan 21, 8:00AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is currently showcasing the company's advanced robotic systems for microarray printing and scanning at the Society for Laboratory Automation and Screening Conference in San Diego, California, USA from January 18-22, 2014. Sponsored by Agilent Technologies, Molecular Devices, Thermo Scientific, and other automation leaders, the conference tagline "An exceptional array of answers" highlights the central role of microarray technology in drug discovery and screening, biomarker identification, nanotechnology, bioinformatics and other conference focus areas.
Arrayit Corporation Participates in the International Plant and Animal Genome Conference XXII; Hosts Technology Workshop "Breakthroughs in Microarray Technology"
Business Wire - Thu Jan 16, 7:30AM CST
Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces that the Company has showcased its leading-edge microarray technology at the 22nd Annual International Plant and Animal Genome Conference (PAG XXII) in San Diego, California, held on January 11-15, 2014. PAG XXII, the largest agricultural genomics meeting in the world, features more than 3,200 scientists, 130 exhibits, 150 workshops, 1,000 posters and 1,800 abstracts. Plant and animal genomics focuses on research and product development based on the DNA sequence genetic blueprints of crop plants, botanical species, livestock, and bacterial and viral pathogens that can compromise food quality and safety.
Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters
Business Wire - Mon Dec 30, 8:05AM CST
Arrayit Corporation (OTCBB: ARYC), a life sciences and molecular diagnostics leader, announces today that the company has commenced business operations from its new corporate headquarters located at 927 Thompson Place in Sunnyvale, California, USA. The new corporate headquarters feature expansive modern offices and meeting rooms, R&D, manufacturing, packaging and shipping facilities, and cleanroom laboratories that are currently undergoing class 100 enhancements and certification for Clinical Laboratories Improvement Amendments (CLIA) and International Organization for Standardization (ISO) 9001 and 13485.
Arrayit makes instrument sale to Canadian research center
M2 - Mon Dec 02, 6:10AM CST
Arrayit Corp. (OTCBB: ARYC) said it has sold a USD166,000 NanoPrint LM60PRO enterprise level protein edition microarray printer and accessories to a top research centre in Ontario, Canada.
Arrayit Corporation Announces Life Sciences Instrument Sale to Top Research Center in Ontario
Business Wire - Wed Nov 27, 7:59AM CST
Arrayit Corporation (OTCBB: ARYC), a life sciences and molecular diagnostics leader, announces today that the company has sold a $166,000 NanoPrint(TM) LM60PRO Enterprise Level Protein Edition Microarray Printer and accessories to a top research center in Ontario, Canada. The Canadian researchers, featured widely in the national and international media, will utilize Arrayit's patented technology to manufacture protein microarrays for exciting interdisciplinary research applications. Arrayit protein microarrays are powerful devices that contain miniaturized collections of intact proteins, the molecules that comprise the building blocks of all living organisms including humans, plants and animals. Protein microarrays empower researchers with the tools needed to study the structure and function of proteins, which are keys to understanding diverse fundamental research topics including the mode of action of pharmaceutical compounds, human disease progression, synthetic and stem cell biology, ecology and population genetics.
Goldman Small Cap Research Initiates Research Coverage of Arrayit Corporation
Marketwire - Tue Nov 26, 7:31AM CST
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has initiated research coverage of Arrayit Corporation (OTCQB: ARYC), a life sciences and molecular diagnostics leader providing a huge suite of tools and integrated systems that empower scientists and clinicians to study all living things, from humans, animals, and plants, to viruses and bacteria.
Arrayit Corporation Announces Microarray Platform Sale to Leading Laboratory in Israel
Business Wire - Fri Nov 22, 7:00AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today that the Company has sold a $129,548 NanoPrint(TM) LM60 Enterprise Level Microarray Printer to a leading research laboratory in Tel Aviv, Israel. Arrayit NanoPrint(TM) instruments enable microarray manufacturing in a high-throughput and highly automated manner using advanced linear drive motion control and linear encoders that permit nanometer positional resolution. Microarrays are biomedical devices that contain genes, proteins, antibodies and other molecules from the human genome and proteome printed at high-density on glass substrates. Patient samples are labeled and reacted with microarrays to provide answers to human health including the pre-symptomatic detection of cancer, autoimmune disease, and other treatable conditions.
Arrayit Corporation To Work With Diagnostic Oncology Research Organization (DOCRO) To Obtain FDA Approvals
Business Wire - Tue Nov 19, 7:30AM CST
Arrayit Corporation (ARYC) announced today that the company has signed a Professional Services Master Agreement (PSMA) with Diagnostic Oncology Research Organization (DOCRO, Inc.). Arrayit and DOCRO will use the PSMA as a blueprint for the submission and approval of the company's OvaDx(R) Pre-Symptomatic Ovarian Cancer Monitoring and Screening Test, as well as a secondary Parkinson's Diagnostic Test and other pipeline tests.
Arrayit Corporation to Host Third Quarter 2013 Earnings Webcast Live on Friday, November 15, 2013
ACCESSWIRE - Thu Nov 14, 8:38AM CST
SUNNYVALE, CA - (ACCESSWIRE - November 14, 2013) - Arrayit Corporation (ARYC) will host a live webcast to discuss the results of the third quarter 2013, to be held Friday, November 15, 2013 at 11:00 a.m. Eastern Time.
Arrayit Corporation Engages Professional Services of Diagnostic Oncology Research Organization
Business Wire - Mon Nov 11, 7:15AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces that it has engaged the professional services of Diagnostic Oncology Contract Research Organization (DOCRO) to assist the Company in its implementation of International Organization of Standardization (ISO) and Clinical Laboratory Improvement Amendments (CLIA) registration and certification.
Arrayit Corporation To Host Conference Call To Discuss Third Quarter 2013 Results
Business Wire - Fri Nov 08, 7:15AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, will host a conference call and webcast on Friday, November 15, 2013 at 11:00 a.m. Eastern Time to discuss the Company's third quarter and nine month results.
ARRAYit Corporation Receives Purchase Order from ChemBio
PR Newswire - Fri Nov 01, 3:29PM CDT
ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $72,297 purchase order from ChemBio, the company's high-powered distributor in Moscow, Russia. ChemBio, which is Russia's premiere distributor of life sciences products and services, represents ARRAYit, Corning, Molecular Devices, Nalgene and other leading corporations, providing Russian customers with market information, technical assistance, installation, product support and training.
Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs
GlobeNewswire - Thu Oct 31, 12:46PM CDT
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today a $39,590 contract award from the United States Department of Veteran Affairs (VA). The VA Healthcare System provides some of the world's finest medicine and cutting-edge technology, as well as a teaching hospital, a full range of patient care services and research in the areas of medicine, surgery, psychiatry, rehabilitation, neurology, oncology, dentistry, geriatrics, and extended care.
Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
PR Newswire - Mon Oct 28, 1:39PM CDT
Arrayit Corporation (OTCQB: ARYC), a leading life sciences and diagnostics company, announces today that the company has signed a seven-year commercial lease for its new corporate headquarters in Sunnyvale, California.
ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
PR Newswire - Thu Oct 24, 5:28AM CDT
ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $104,000 purchase order from the University of California for its life science instruments product line.
ARRAYit Corporation reports delivery of proprietary life sciences products to Illumina Inc
M2 - Tue Oct 22, 4:51AM CDT
Life science company ARRAYit Corporation (Other OTC:ARYC) reported on Monday the shipment of its proprietary microarray life sciences products to Illumina Inc (NasdaqGS:ILMN).
ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
PR Newswire - Mon Oct 21, 9:37AM CDT
ARRAYit Corporation (OTCQB: ARYC) has shipped its proprietary life sciences products to search engine giant Google Inc. (NASDAQ: GOOG). ARRAYit is a microarray technology leader offering platforms, instruments, tools, kits and reagents to empower human genome discoveries including the ability to decipher all 6,000 human diseases.
ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
PR Newswire - Mon Oct 21, 7:34AM CDT
ARRAYit Corporation (OTCQB: ARYC) announces that the company has shipped its proprietary microarray life sciences products to Illumina Inc. (NASDAQ: ILMN), a developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and biological function using its proprietary bead array and solid phase sequencing technologies to empower DNA microarray and next generation sequencing (NGS) applications.
ARRAYit Announces New Funding and New Director
PR Newswire - Tue Oct 15, 8:32AM CDT
ARRAYit Corporation (OTCQB: ARYC) is pleased to announce a non brokered financing with selected accredited investors at 30 cents with 50% warrant coverage at $0.45. Closing to be 10/18/13.
Arrayit Corporation Showcases High Sensitivity Diagnostic Microarray Technology at 21st International Molecular Medicine Tri-Conference
GlobeNewswire - Mon Feb 10, 12:09PM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is showcasing its high sensitivity, high specificity patented and proprietary microarray platform at the 21 International Molecular Medicine Tri-Conference in San Francisco, CA, USA on February 9-14, 2014. The conference, which features more than 3,000 researchers and clinicians from 35 countries, focuses on drug discovery, genomics, diagnostics and information technology.
Arrayit Corporation Showcases Advanced Robotic Microarray Technology at Laboratory Automation Conference 2014
GlobeNewswire - Tue Jan 21, 8:00AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, is currently showcasing the company's advanced robotic systems for microarray printing and scanning at the Society for Laboratory Automation and Screening Conference in San Diego, California, USA from January 18-22, 2014. Sponsored by Agilent Technologies, Molecular Devices, Thermo Scientific, and other automation leaders, the conference tagline "An exceptional array of answers" highlights the central role of microarray technology in drug discovery and screening, biomarker identification, nanotechnology, bioinformatics and other conference focus areas.
Arrayit Corporation Participates in the International Plant and Animal Genome Conference XXII; Hosts Technology Workshop "Breakthroughs in Microarray Technology"
Business Wire - Thu Jan 16, 7:30AM CST
Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces that the Company has showcased its leading-edge microarray technology at the 22nd Annual International Plant and Animal Genome Conference (PAG XXII) in San Diego, California, held on January 11-15, 2014. PAG XXII, the largest agricultural genomics meeting in the world, features more than 3,200 scientists, 130 exhibits, 150 workshops, 1,000 posters and 1,800 abstracts. Plant and animal genomics focuses on research and product development based on the DNA sequence genetic blueprints of crop plants, botanical species, livestock, and bacterial and viral pathogens that can compromise food quality and safety.
Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters
Business Wire - Mon Dec 30, 8:05AM CST
Arrayit Corporation (OTCBB: ARYC), a life sciences and molecular diagnostics leader, announces today that the company has commenced business operations from its new corporate headquarters located at 927 Thompson Place in Sunnyvale, California, USA. The new corporate headquarters feature expansive modern offices and meeting rooms, R&D, manufacturing, packaging and shipping facilities, and cleanroom laboratories that are currently undergoing class 100 enhancements and certification for Clinical Laboratories Improvement Amendments (CLIA) and International Organization for Standardization (ISO) 9001 and 13485.
Arrayit makes instrument sale to Canadian research center
M2 - Mon Dec 02, 6:10AM CST
Arrayit Corp. (OTCBB: ARYC) said it has sold a USD166,000 NanoPrint LM60PRO enterprise level protein edition microarray printer and accessories to a top research centre in Ontario, Canada.
Arrayit Corporation Announces Life Sciences Instrument Sale to Top Research Center in Ontario
Business Wire - Wed Nov 27, 7:59AM CST
Arrayit Corporation (OTCBB: ARYC), a life sciences and molecular diagnostics leader, announces today that the company has sold a $166,000 NanoPrint(TM) LM60PRO Enterprise Level Protein Edition Microarray Printer and accessories to a top research center in Ontario, Canada. The Canadian researchers, featured widely in the national and international media, will utilize Arrayit's patented technology to manufacture protein microarrays for exciting interdisciplinary research applications. Arrayit protein microarrays are powerful devices that contain miniaturized collections of intact proteins, the molecules that comprise the building blocks of all living organisms including humans, plants and animals. Protein microarrays empower researchers with the tools needed to study the structure and function of proteins, which are keys to understanding diverse fundamental research topics including the mode of action of pharmaceutical compounds, human disease progression, synthetic and stem cell biology, ecology and population genetics.
Goldman Small Cap Research Initiates Research Coverage of Arrayit Corporation
Marketwire - Tue Nov 26, 7:31AM CST
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has initiated research coverage of Arrayit Corporation (OTCQB: ARYC), a life sciences and molecular diagnostics leader providing a huge suite of tools and integrated systems that empower scientists and clinicians to study all living things, from humans, animals, and plants, to viruses and bacteria.
Arrayit Corporation Announces Microarray Platform Sale to Leading Laboratory in Israel
Business Wire - Fri Nov 22, 7:00AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today that the Company has sold a $129,548 NanoPrint(TM) LM60 Enterprise Level Microarray Printer to a leading research laboratory in Tel Aviv, Israel. Arrayit NanoPrint(TM) instruments enable microarray manufacturing in a high-throughput and highly automated manner using advanced linear drive motion control and linear encoders that permit nanometer positional resolution. Microarrays are biomedical devices that contain genes, proteins, antibodies and other molecules from the human genome and proteome printed at high-density on glass substrates. Patient samples are labeled and reacted with microarrays to provide answers to human health including the pre-symptomatic detection of cancer, autoimmune disease, and other treatable conditions.
Arrayit Corporation To Work With Diagnostic Oncology Research Organization (DOCRO) To Obtain FDA Approvals
Business Wire - Tue Nov 19, 7:30AM CST
Arrayit Corporation (ARYC) announced today that the company has signed a Professional Services Master Agreement (PSMA) with Diagnostic Oncology Research Organization (DOCRO, Inc.). Arrayit and DOCRO will use the PSMA as a blueprint for the submission and approval of the company's OvaDx(R) Pre-Symptomatic Ovarian Cancer Monitoring and Screening Test, as well as a secondary Parkinson's Diagnostic Test and other pipeline tests.
Arrayit Corporation to Host Third Quarter 2013 Earnings Webcast Live on Friday, November 15, 2013
ACCESSWIRE - Thu Nov 14, 8:38AM CST
SUNNYVALE, CA - (ACCESSWIRE - November 14, 2013) - Arrayit Corporation (ARYC) will host a live webcast to discuss the results of the third quarter 2013, to be held Friday, November 15, 2013 at 11:00 a.m. Eastern Time.
Arrayit Corporation Engages Professional Services of Diagnostic Oncology Research Organization
Business Wire - Mon Nov 11, 7:15AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces that it has engaged the professional services of Diagnostic Oncology Contract Research Organization (DOCRO) to assist the Company in its implementation of International Organization of Standardization (ISO) and Clinical Laboratory Improvement Amendments (CLIA) registration and certification.
Arrayit Corporation To Host Conference Call To Discuss Third Quarter 2013 Results
Business Wire - Fri Nov 08, 7:15AM CST
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, will host a conference call and webcast on Friday, November 15, 2013 at 11:00 a.m. Eastern Time to discuss the Company's third quarter and nine month results.
ARRAYit Corporation Receives Purchase Order from ChemBio
PR Newswire - Fri Nov 01, 3:29PM CDT
ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $72,297 purchase order from ChemBio, the company's high-powered distributor in Moscow, Russia. ChemBio, which is Russia's premiere distributor of life sciences products and services, represents ARRAYit, Corning, Molecular Devices, Nalgene and other leading corporations, providing Russian customers with market information, technical assistance, installation, product support and training.
Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs
GlobeNewswire - Thu Oct 31, 12:46PM CDT
Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today a $39,590 contract award from the United States Department of Veteran Affairs (VA). The VA Healthcare System provides some of the world's finest medicine and cutting-edge technology, as well as a teaching hospital, a full range of patient care services and research in the areas of medicine, surgery, psychiatry, rehabilitation, neurology, oncology, dentistry, geriatrics, and extended care.
Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
PR Newswire - Mon Oct 28, 1:39PM CDT
Arrayit Corporation (OTCQB: ARYC), a leading life sciences and diagnostics company, announces today that the company has signed a seven-year commercial lease for its new corporate headquarters in Sunnyvale, California.
ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
PR Newswire - Thu Oct 24, 5:28AM CDT
ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $104,000 purchase order from the University of California for its life science instruments product line.
ARRAYit Corporation reports delivery of proprietary life sciences products to Illumina Inc
M2 - Tue Oct 22, 4:51AM CDT
Life science company ARRAYit Corporation (Other OTC:ARYC) reported on Monday the shipment of its proprietary microarray life sciences products to Illumina Inc (NasdaqGS:ILMN).
ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
PR Newswire - Mon Oct 21, 9:37AM CDT
ARRAYit Corporation (OTCQB: ARYC) has shipped its proprietary life sciences products to search engine giant Google Inc. (NASDAQ: GOOG). ARRAYit is a microarray technology leader offering platforms, instruments, tools, kits and reagents to empower human genome discoveries including the ability to decipher all 6,000 human diseases.
ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
PR Newswire - Mon Oct 21, 7:34AM CDT
ARRAYit Corporation (OTCQB: ARYC) announces that the company has shipped its proprietary microarray life sciences products to Illumina Inc. (NASDAQ: ILMN), a developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and biological function using its proprietary bead array and solid phase sequencing technologies to empower DNA microarray and next generation sequencing (NGS) applications.
ARRAYit Announces New Funding and New Director
PR Newswire - Tue Oct 15, 8:32AM CDT
ARRAYit Corporation (OTCQB: ARYC) is pleased to announce a non brokered financing with selected accredited investors at 30 cents with 50% warrant coverage at $0.45. Closing to be 10/18/13.
(0)
(0)